Case Study

New

Development of Tri-specific Neutralizing Antibodies for the Treatment of COVID-19

case study
case Study

Development of serial internalization antibodies

case study

Development of a novel "imbalanced" CSA bispecific antibody by computational design

Publications

01

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

Here we describe using humanized llama antibody VHHs against SARS-CoV-2 that would overcome the limitations associated with...

02

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

A promising approach to combat COVID-19 is through the neutralization of SARS-CoV-2 by therapeutic antibodies. Previously, we described...

shape section shape